A recently published study showed that Qihuang needle acupuncture significantly improved motor function, nonmotor symptoms, and quality of life in patients with PD when added to standard medication.
Blog|Articles|November 7, 2017
Impulse Control Disorder in Parkinson Disease: 3 Questions
Author(s)Jacob Taylor, MD, MPH, Gregory Pontone, MD
Delirium, psychosis, impulse control disorders: these are among the psychiatric problems associated with dopaminergic medications that control PD motor symptoms. Take the quiz.
Advertisement
Question 1 (Answer and Question #2 on Next Page »):
Answer and Question #2 on Next Page »
The correct answer is B
Question 2 (Answer and Question #3 on Next Page »):
Answer and Question #3 on Next Page »
The correct answer is C
Question 3: (Answer on next page >)
The correct answer is B
For more on this topic, see Implications of Impulse Control Disorder in Parkinson Disease, on which this quiz is based.
Advertisement
Related to this article
The approval, based on phase 3 IB1001-303 trial data showing consistent SARA scale improvement, makes levacetylleucine the first treatment approved specifically for ataxia-telangiectasia.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 18, 2026.
Michela Leocadi, PhD, research fellow at UCL Queen Square Institute of Neurology, discussed new longitudinal data showing early functional connectivity changes in HD gene carriers years before clinical motor diagnosis.
In a phase 4 randomized controlled trial, opicapone failed to demonstrate statistical superiority over placebo for reducing fluctuation-related pain in patients living with Parkinson disease.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Ulefnersen Meets Primary End Point in Phase 3 FUSION Trial for FUS-ALS
2
Xenon Submits New Drug Application for Azetukalner as Treatment for Focal Seizures
3
Gefurulimab Recommended for EU Approval in Generalized Myasthenia Gravis
4
Group-Based Resilience Program Improves Psychological Outcomes in Multiple Sclerosis
5